Literature DB >> 9112987

Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis.

S A Masinick1, C P Montgomery, P C Montgomery, L D Hazlett.   

Abstract

PURPOSE: To determine whether secretory IgA (SIgA) antibody inhibits Pseudomonas aeruginosa binding to cornea in vitro and if boosting SIgA antibody in tears using heat-killed P. aeruginosa as an immunizing antigen is protective in vivo in experimentally induced bacterial keratitis in the mouse.
METHODS: SIgA, immunoglobulin-G, immunoglobulin-M, and an undiluted crude human milk preparation were tested in vitro for their ability to inhibit P. aeruginosa binding to the scarified corneas of adult (6 weeks to 6 months of age) mice by topical application of each before similar delivery of the bacterial inoculum. Scanning electron microscopy (scanning EM) was used to quantitate bacterial adherence. In vivo mice were immunized topically with heat-killed P. aeruginosa or sham immunized by application of a similar volume of phosphate-buffered saline (PBS). Tears were collected from both groups of mice and levels of immunoglobulins (Igs) measured by enzyme-linked immunosorbent assay (ELISA). After the second immunization, the same two groups were challenged ocularly with 5.0 x 10(7) colony forming units P. aeruginosa and the response to infection graded.
RESULTS: In vitro, after a 30-minute preincubation with Igs, SIgA (250 micrograms/ml) significantly decreased P. aeruginosa binding to cornea in vitro when compared to the number of bacteria bound in PBS control specimens, and binding reduction was concentration dependent. In vivo, 15 days after a second ocular topical immunization, tear SIgA was elevated significantly and was specific for P. aeruginosa when measured by ELISA. In vivo, corneal disease response grades in the heat-killed antigen immunized mice also were significantly less severe when compared to sham-immunized mice.
CONCLUSIONS: SIgA significantly inhibits binding of P. aeruginosa to the wounded mouse cornea in vitro, and inhibition is concentration dependent. In vivo, specific antipseudomonal SIgA in mouse tears can be elicited by topical ocular immunization with heat-killed P. aeruginosa, and a significant number of immunized animals with elevated levels of SIgA in their tears exhibited less severe ocular disease after bacterial challenge.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9112987

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  23 in total

1.  Development of a novel ex vivo model of corneal fungal adherence.

Authors:  Qingjun Zhou; Hao Chen; Mingli Qu; Qian Wang; Lingling Yang; Lixin Xie
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-12-24       Impact factor: 3.117

2.  Factors impacting corneal epithelial barrier function against Pseudomonas aeruginosa traversal.

Authors:  Irania Alarcon; Connie Tam; James J Mun; Jeffrey LeDue; David J Evans; Suzanne M J Fleiszig
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-14       Impact factor: 4.799

3.  Effector mechanisms of protection against Pseudomonas aeruginosa keratitis in immunized rats.

Authors:  A Thakur; J Kyd; M Xue; M D Willcox; A Cripps
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Role of defensins in corneal epithelial barrier function against Pseudomonas aeruginosa traversal.

Authors:  Danielle K Augustin; Susan R Heimer; Connie Tam; Wing Y Li; Jeff M Le Due; David J Evans; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2010-11-29       Impact factor: 3.441

5.  Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa.

Authors:  Minjian Ni; David J Evans; Samuel Hawgood; E Margot Anders; Robert A Sack; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  Corneal surface glycosylation is modulated by IL-1R and Pseudomonas aeruginosa challenge but is insufficient for inhibiting bacterial binding.

Authors:  Amber L Jolly; Paresh Agarwal; Matteo M E Metruccio; David R Spiciarich; David J Evans; Carolyn R Bertozzi; Suzanne M J Fleiszig
Journal:  FASEB J       Date:  2017-02-21       Impact factor: 5.191

7.  Degradation of immunoglobulins, protease inhibitors and interleukin-1 by a secretory proteinase of Acanthamoeba castellanii.

Authors:  Byoung-Kuk Na; Jung-Hwa Cho; Chul-Yong Song; Tong-Soo Kim
Journal:  Korean J Parasitol       Date:  2002-06       Impact factor: 1.341

8.  Why does the healthy cornea resist Pseudomonas aeruginosa infection?

Authors:  David J Evans; Suzanne M J Fleiszig
Journal:  Am J Ophthalmol       Date:  2013-04-17       Impact factor: 5.258

9.  Modification of Pseudomonas aeruginosa interactions with corneal epithelial cells by human tear fluid.

Authors:  Suzanne M J Fleiszig; Mary S F Kwong; David J Evans
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

10.  Clearance of Pseudomonas aeruginosa from a healthy ocular surface involves surfactant protein D and is compromised by bacterial elastase in a murine null-infection model.

Authors:  James J Mun; Connie Tam; David Kowbel; Samuel Hawgood; Mitchell J Barnett; David J Evans; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2009-04-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.